Skip to content
StockMarketAgent
Healthcare / Medical - Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

AIM/PRM stock hub

AIM/PRM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

AIM/PRMis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
4.9M
London Stock Exchange AIM
Market data

Live price

Current market quote for this ticker.

Current price
AIM/PRM
In the news

Latest news · AIM/PRM

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.9P50 16.9P75 23.5
Trailing P/En/a
P25 15.9P50 22.9P75 35.8
ROEn/a
P25 -54.2P50 2.1P75 13.7
ROIC-48.8
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All AIM/PRM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
182
Groups with data
11
Currency
GBP
Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
United Kingdom
Country code
UK
Employees
32
Employees Change
-4%
Employees Change Percent
-11.11
Enterprise value
GBX 19.9M
Exchange
London Stock Exchange AIM
Financial currency
GBP
First seen
2026-05-10
Industry
Medical - Diagnostics & Research
Isin
GB0003104196
Last refreshed
2026-05-10
Market cap
GBX 4.9M
Price
GBX 1.4
Price currency
GBX
Rev Per Employee
117,375x
Sector
Healthcare
Sic
8731
Symbol
aim/PRM
Website
https://www.proteomics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-62.34%
EV Earnings
-6.5x
EV/FCF
-139.15x
EV/Sales
5.3x
FCF yield
-2.91%
P/B ratio
-0.52x
P/S ratio
1.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

15
MetricValue
EBIT Margin
-70.98%
EBITDA Margin
-66.19%
Gross margin
-2.16%
Gross Profit
GBX -81,000
Net Income
GBX -3.1M
Net Income Growth Quarters
3%
Net Income Growth Years
1%
Pretax Margin
-95.61%
Profit Margin
-81.5%
Profit Per Employee
GBX -95,656
ROA
-19.2
Roa5y
-5.94
ROCE
32.06
ROIC
-48.85
Roic5y
-13.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

13
MetricValue
Cagr10y
-23.16%
Cagr15y
-17.34%
Cagr1y
-53.36%
Cagr20y
-15.6%
Cagr3y
-30.93%
Cagr5y
-32.38%
EPS Growth Quarters
3
EPS Growth Years
1
Revenue Growth
-23.14x
Revenue Growth Q
-28.88x
Revenue Growth Years
0x
Revenue Growth3 Y
-2.36x
Revenue Growth5 Y
-13.48x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Asset Turnover
GBX 0.43
Assets
GBX 8.3M
Cash
GBX 781,000
Current Assets
GBX 2.1M
Current Liabilities
GBX 16.6M
Debt
GBX 15.8M
Debt FCF
GBX -110
Equity
GBX -9.5M
Interest Coverage
-2.88
Liabilities
GBX 17.8M
Long Term Assets
GBX 6.2M
Long Term Liabilities
GBX 1.2M
Net Cash
GBX -15M
Net Cash By Market Cap
GBX -305
Tangible Book Value
GBX -13.7M
Tangible Book Value Per Share
GBX -0.05
WACC
4.84

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.13
Inventory Turnover
6.05
Net Working Capital
GBX -333,000
Quick ratio
0.09
Working Capital
GBX -14.5M
Working Capital Turnover
GBX -0.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
0.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-92.82%
1Y total return
-53.33%
200-day SMA
2.22
3Y total return
-67.06%
50-day SMA
1.6
50-day SMA vs 200-day SMA
50under200
5Y total return
-85.86%
All Time High
241
All Time High Change
-99.42%
All Time High Date
2003-12-15
All Time Low
1.2
All Time Low Change
16.67%
All Time Low Date
2004-05-04
ATR
0.23
Beta
0.22
Beta1y
0.55
Beta2y
0.11
Ch YTD
-44
High
1.4
High52
4.4
High52 Date
2026-01-14
High52ch
-68.18%
Low
1.4
Low52
1.2
Low52 Date
2026-04-21
Low52ch
16.67%
Ma50ch
-12.28%
Price vs 200-day SMA
-36.97%
RSI
43.11
RSI Monthly
37.22
RSI Weekly
39.69
Sharpe ratio
0.01x
Sortino ratio
0.06
Total Return
0.81%
Tr YTD
-44
Tr15y
-94.26%
Tr1m
-11.39%
Tr1w
-16.67%
Tr3m
-20.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
GBX -2.7M
Operating margin
-70.98

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
221,679,464%
Net Borrowing
-204,000
Shares Insiders
12.13%
Shares Institutions
49.2%
Shares Out
350,724,912
Shares Qo Q
6.54%
Shares Yo Y
-0.81%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

55
MetricValue
Adjusted FCF
GBX -161,000
Average Volume
421,715.75x
Bv Per Share
-0.03
CAPEX
GBX -97,000
Ch10y
-92.82
Ch15y
-94.26
Ch1m
-11.39
Ch1w
-16.67
Ch1y
-53.33
Ch20y
-96.67
Ch3m
-20.9
Ch3y
-67.06
Ch5y
-85.86
Ch6m
-9.68
Change
-15.41%
Change From Open
0
Close
1.66
Days Gap
-15.41
Depreciation Amortization
180,000
Dollar Volume
1.4
Earnings Date
2026-06-25
EBIT
GBX -2.7M
EBITDA
GBX -2.5M
EPS
GBX -0.01
F Score
2
FCF
GBX -143,000
FCF EV Yield
-0.72x
FCF Per Share
GBX -0
Financing CF
-204,000
Fiscal Year End
December
Founded
1,993
Goodwill
4,218,000
Income Tax
GBX -530,000
Investing CF
-97,000
Is Primary Listing
1
Last Earnings Date
2025-08-04
Last Report Date
2025-12-31
Ma150
1.96
Ma150ch
-28.72%
Ma20
1.46
Ma20ch
-4.31%
Net CF
-347,000
Next Earnings Date
2026-06-25
Open
1.4
Ppne
1,965,000
Price Date
2026-05-08
Relative Volume
0x
Revenue
3,756,000x
SBC By Revenue
0.48x
Share Based Comp
18,000
Tax By Revenue
-14.11x
Tr20y
-96.64%
Tr6m
-9.68%
Volume
1
Z Score
-15.89
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does AIM/PRM pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/PRM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-53.3%
S&P 500 1Y: n/a
3Y total return
-67.1%
S&P 500 3Y: n/a
5Y total return
-85.9%
S&P 500 5Y: n/a
10Y total return
-92.8%
S&P 500 10Y: n/a
Ownership

Who owns AIM/PRM?

Insider, institutional, and short-interest positioning.

Institutional ownership
+49.2%
Share of float held by funds and institutions
Insider ownership
+12.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.8%
Negative means the company is buying back shares.
Technical

AIM/PRM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
43.1
Neutral momentum band
Price vs 200-day MA
-37.0%
50/200-day relationship not available
Beta (5Y)
0.22
Less volatile than the market
Sharpe ratio
0.01
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About AIM/PRM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/PRM stock rating?

aim/PRM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/PRM analysis?

The full report lives at /stocks/aim/PRM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/PRM?

The latest report frames aim/PRM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/PRM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.